AstraZeneca (United Kingdom)-ko ikertzaileekin lankidetzan egindako argitalpenak (2)

1997

  1. Phase II trial of raltitrexed ('Tomudex') in advanced small-cell lung cancer

    British Journal of Cancer, Vol. 76, Núm. 2, pp. 264-265

1995

  1. 'Tomudex' (ZD1694): Results of a randomised trial in advanced colorectal cancer demonstrate efficacy and reduced mucositis and leucopenia

    European Journal of Cancer, Vol. 31, Núm. 12, pp. 1945-1954